The banned companies are Goodearth Financial Services, Ebers Pharmaceuticals, Elegant Pharmaceuticals, Damania Capital Markets and Shree Pomani Metals & Alloys.
In addition, Securities and Exchange Board of India (Sebi) has restrained the directors of Damania Capital Markets and Shree Pomani Metals & Alloys from the securities markets.
In five similar-worded orders, Sebi has restrained these firms from "accessing the securities market and from buying, selling or dealing in securities, directly or indirectly, in whatsoever manner, till it resolves all the investor grievances pending against it".
The capital markets watchdog noted that some of the complaints were pending unresolved since 2001.
Most of the complaints were related to non-receipt of shares after transfer as well as non-receipt of funds in rights and other public issue.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
